Hancock Jaffe Laboratories, Inc. Made Headway

Wed, Feb 12, 2020 at 05:30 PM
Hancock Jaffe Laboratories, Inc. Made Headway

Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ) rocketted at $0.75, representing a gain of 25.9%. On Tue 11 Feb 20, HJLI:NASDAQ touched a New 2-Week Intraday High of $0.62. From Wed 22 Jan 20, the stock recorded 50.00% Up Days and 33.33% Green Days

The share price of the company has been moving sideways in recent weeks.

About Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ)

Hancock Jaffe Laboratories Inc development stage medical device company. It develops and sells biological tissue solutions to treat patients with coronary, vascular, end stage renal and peripheral arterial diseases in the United States and Europe.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.